Dummy data - for testing purposes only

Objective 5 · O5·KR1

Grow revenue while improving the economics and reliability of each appointment.

Increase net revenue by 35%.

On track

Baseline

100 $M (indexed)

Current

127 $M (indexed)

Target

135 $M (indexed)

Progress to target

77%

Weekly trendLast 10 weeks

Ownership

RFRutger Flohil

Team: Growth

Objective lead: Rob Sadow

Key risks

  • Regulatory review required
  • Dependency on payer partner timelines

Update history

  1. Nov 4, 2026·Rutger FlohilOn track

    Volume and rate mix ahead of plan; Q4 forecast reaffirmed.

  2. Oct 21, 2026·Jake PosesAt risk

    Mid-quarter review complete; plan adjusted based on latest data.

  3. Oct 7, 2026·Rob SadowOn track

    Kickoff: baseline locked, initiatives staffed.